CoChat

Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors

Open access
Duarte-Pereira, Sara, Pereira-Castro, Isabel, Silva, Sarah S., Correia, Mariana Gonçalves, Neto, Célia, da Costa, Luís Teixeira, Amorim, António, Silva, Raquel M. · 2016 · Oncotarget
Cited by 66

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

// Sara Duarte-Pereira 1 , Isabel Pereira-Castro 1,6 , Sarah S. Silva 1 , Mariana Gonçalves Correia 1 , Célia Neto 1 , Luís Teixeira da Costa 1,2 , António Amorim 1,3,4 and Raquel M. Silva 1,5 1 IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal 2 ICAAM - Instituto de Ciências Agrárias e Ambientais Mediterrânicas, University of Évora, Évora, Portugal 3 Faculty of Sciences, University of Porto, Porto, Portugal 4 Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal 5 Institute for Biomedicine - iBiMED & IEETA, University of Aveiro, Aveiro, Portugal 6 Gene Regulation Group, i3S/IBMC - Instituto de Investigação e Inovação em Saúde/Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal Correspondence to: Raquel M. Silva, email: // Keywords : human NAD salvage, NAPRT, NAMPT, alternative transcripts, anti-cancer therapies Received : June 23, 2015 Accepted : November 21, 2015 Published : December 09, 2015 Abstract Nicotinamide adenine dinucleotide (NAD) is a cofactor in redox reactions and a substrate for NAD-consuming enzymes, such as PARPs and sirtuins. As cancer cells have increased NAD requirements, the main NAD salvage enzymes in humans, nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase (NAPRT), are involved in the development of novel anti-cancer therapies. Knowledge of the expression patterns of both genes in tissues and tumors is critical for the use of nicotinic acid (NA) as cytoprotective in therapies using NAMPT inhibitors. Herein, we provide a comprehensive study of NAPRT and NAMPT expression across human tissues and tumor cell lines. We show that both genes are widely expressed under normal conditions and describe the occurrence of novel NAPRT transcripts. Also, we explore some of the NAPRT gene expression mechanisms. Our findings underline that the efficiency of NA in treatments with NAMPT inhibitors is dependent on the knowledge of the expression profiles and regulation of both NAMPT and NAPRT .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6538

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 66

Metadata

Authors
Duarte-Pereira, S., Pereira-Castro, I., Silva, S. S., Correia, M. G., Neto, C., da Costa, L. T., Amorim, A., & Silva, R. M.
Venue
Oncotarget
Published
2015-12-09
Volume
7
Issue
2
Pages
1973-1983
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2235472906
Cited by
66
References
13
FWCI
1.98
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.